Literature DB >> 7685195

Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia.

U J Woermann1, R Schenk, A Zimmermann, A Tobler.   

Abstract

Recombinant human granulocyte colony-stimulating factor (rhG-CSF) has been used mainly for treatment of chemotherapy-induced neutropenia. The reported side effects were of minor importance. We describe a case of long-term treatment with rhG-CSF, in which we observed enhanced bone remodeling.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7685195     DOI： 10.1007/bf01738479

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


  9 in total

Review 1.  Granulocyte colony-stimulating factor and its receptor.

Authors:  G D Demetri; J D Griffin
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

2.  Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.

Authors:  W P Hammond; T H Price; L M Souza; D C Dale
Journal:  N Engl J Med       Date:  1989-05-18       Impact factor: 91.245

3.  Quantitative structural analysis of human cancellous bone.

Authors:  W A Merz; R K Schenk
Journal:  Acta Anat (Basel)       Date:  1970

4.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.

Authors:  K Welte; C Zeidler; A Reiter; W Müller; E Odenwald; L Souza; H Riehm
Journal:  Blood       Date:  1990-03-01       Impact factor: 22.113

5.  A quantitative histological study on bone formation in human cancellous bone.

Authors:  W A Merz; R K Schenk
Journal:  Acta Anat (Basel)       Date:  1970

6.  Relation between erythropoiesis and bone metabolism in thalassemia.

Authors:  P Pootrakul; S Hungsprenges; S Fucharoen; D Baylink; E Thompson; E English; M Lee; J Burnell; C Finch
Journal:  N Engl J Med       Date:  1981-06-11       Impact factor: 91.245

7.  Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis.

Authors:  M A Bonilla; A P Gillio; M Ruggeiro; N A Kernan; J A Brochstein; M Abboud; L Fumagalli; M Vincent; J L Gabrilove; Karl Welte; Lawrence M Souza; Richard J O'Reilly
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

8.  Bone modulation in sustained hematopoietic stimulation in mice.

Authors:  M Y Lee; R Fukunaga; T J Lee; J L Lottsfeldt; S Nagata
Journal:  Blood       Date:  1991-05-15       Impact factor: 22.113

9.  Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy.

Authors:  G Morstyn; L Campbell; L M Souza; N K Alton; J Keech; M Green; W Sheridan; D Metcalf; R Fox
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.